| Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial 2008 · Multiple micronutrients · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation | 30 mg | 70 mg | — | 1,899 |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · EMMS (early food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | 70 mg | — | — |
| Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh 2014 · UMMS (usual food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation | 30 mg | 70 mg | — | — |
| Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial 2016 · MMN group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation | 30 mg | 70 mg | — | — |
| Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial 2022 · MNPs with placebo syrup · Children screened at 8 months of age in rural Bangladesh; both sexes; no condition required for eligibility | 12.5 mg | — | 90 days | 1,099 |
| Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial 2024 · oral ferrous sulphate group · Pregnant women aged 15–49 years, 20–32 weeks’ gestation, with haemoglobin below 10 g/dL | 600 mg | 300 mg | — | 529 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · weekly supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 17.1 mg | 14.3 mg | — | 149 |
| Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy 2018 · daily supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation | 60 mg | 100 mg | — | 143 |
| Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods 2001 · sprinkles group · Anemic children aged 6–18 months in rural Ghana | 80 mg | — | 60 days | — |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 5.8 mg | 48 mg | 26 weeks | — |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 12.5 mg | 30 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 9.6 mg | 40.2 mg | 1 year | 316 |
| Regular vitamin C supplementation during pregnancy reduces hospitalization: outcomes of a Ugandan rural cohort study 2010 · Vitamin C group · Pregnant women aged at least 18, enrolled at 4–12 gestational weeks in Uganda | 200 mg | 400 mg | — | 187 |
| Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status 2006 · supplementation group · Pregnant women screened positive for low antioxidant status at 8 to 12 weeks of gestation | 30 mg | 200 mg | — | 29 |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 18 mg | 50 mg | 335 days | — |
| Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa 2009 · multiple micronutrients · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers | 10 mg | 35 mg | 548 days | — |
| Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam 2017 · MM (multiple micronutrients) preconception group · Women of reproductive age in Vietnam intending to become pregnant | 8.57 mg | 10 mg | 54 weeks | 1,469 |
| Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial 2008 · intervention group · Pregnant women enrolled at no earlier than 12 weeks’ gestation, with singleton pregnancies and gestation up to 20 completed weeks | 30 mg | 70 mg | — | 600 |
| Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial 2014 · intervention group (multiple micronutrient supplement) · Pregnant women attending antenatal care in Nepal; no specific age range or deficiency criterion stated | 30 mg | 70 mg | — | 600 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-180 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 70 mg | 180 days | 516 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 70 mg | 180 days | 515 |
| Maternal iron deficiency anemia affects postpartum emotions and cognition 2005 · daily iron · Young postpartum mothers with iron-deficiency anemia; age range not stated | 125 mg | 25 mg | 26 weeks | — |
| Mother-infant interactions and infant development are altered by maternal iron deficiency anemia 2005 · daily iron treatment · Anemic mothers of full-term, normal-birth-weight infants; maternal age not stated | 125 mg | — | — | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 9.6 mg | 40.2 mg | 1 year | 316 |
| Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months 2010 · Multiple micronutrients · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes | 10 mg | 35 mg | 548 days | 126 |
| Acceptability of multiple micronutrient powders and iron syrup in Bihar, India 2018 · multiple micronutrient powder (MNP) · Children aged 6–23 months in rural Bihar, not currently taking iron supplements | 12.5 mg | 30 mg | 30 days | 100 |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group II · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 6 mg | 500 mg | 9 weeks | — |
| Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise 1991 · Group IV · Female college-student volunteers with iron-deficiency anemia or severe latent iron deficiency | 6 mg | 500 mg | 9 weeks | — |
| Associations of antenatal micronutrient supplementation with adolescent blood pressure: evidence from a 14-year follow-up study of a randomized controlled trial 2025 · Multiple micronutrients (MMNs; UNIMMAP formulation) · Pregnant women less than 28 weeks of gestation; offspring were followed up at ages 10–14 years | 30 mg | 70 mg | — | — |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · micronutrient powder (MNP) · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | — | 120 days | 105 |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · micronutrient syrup · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | — | 120 days | 105 |
| Consumption of Micronutrient Powder, Syrup or Fortified Food Significantly Improves Zinc and Iron Status in Young Mexican Children: A Cluster Randomized Trial 2022 · fortified food (FF) · Children aged 6–12 months in urban communities in southern Mexico, beneficiaries of the Prospera program | 10 mg | — | 120 days | 73 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group B · Healthy adult volunteers; sex and age range not stated | 14 mg | 260 mg | 12 weeks | 20 |
| Potential problems of ascorbate and iron supplementation: pro-oxidant effect in vivo? 2000 · 260 mg/d ascorbate plus 14 mg/d iron · 20 healthy subjects | 14 mg | 260 mg | 6 weeks | — |
| Vitamin C-Rich Guava Consumed with Mungbean Dal Reduces Anemia and Increases Hemoglobin but not Iron Stores: A Randomized Controlled Trial of Food-to-Food Fortification in Indian Children 2024 · mungbean dal with fresh guava · Children aged 6–10 years in rural Haryana, India; the group included children with and without anemia or iron deficiency | 3.2 mg | 170 mg | 213 days | — |
| The effect of a micronutrient powder home fortification program on anemia and cognitive outcomes among young children in rural China: a cluster randomized trial 2017 · Free MNP Group · Children aged 6–11 months at enrollment in rural southern Shaanxi, China; no specific diagnosed condition stated | 6 mg | 50 mg | 548 days | 1,192 |
| Effect of low-iron micronutrient powder (MNP) on the composition of gut microbiota of Bangladeshi children in a high-iron groundwater setting: a randomized controlled trial 2021 · Low-iron MNP · Children aged 2–5 years living in Belkuchi, Bangladesh, exposed to high-iron groundwater | 5 mg | 30 mg | 60 days | 27 |
| Effect of low-iron micronutrient powder (MNP) on the composition of gut microbiota of Bangladeshi children in a high-iron groundwater setting: a randomized controlled trial 2021 · Standard MNP · Children aged 2–5 years living in Belkuchi, Bangladesh, exposed to high-iron groundwater | 12.5 mg | 30 mg | 60 days | 26 |
| Effect of Micronutrient Powder (MNP) with a Low-Dose of Iron on Hemoglobin and Iron Biomarkers, and Its Effect on Morbidities in Rural Bangladeshi Children Drinking Groundwater with a High-Level of Iron: A Randomized Controlled Trial 2019 · low-dose-iron MNP · Bangladeshi children aged 2–5 years drinking groundwater with a high level of iron | 5 mg | 30 mg | 60 days | — |
| Effect of Micronutrient Powder (MNP) with a Low-Dose of Iron on Hemoglobin and Iron Biomarkers, and Its Effect on Morbidities in Rural Bangladeshi Children Drinking Groundwater with a High-Level of Iron: A Randomized Controlled Trial 2019 · standard MNP · Bangladeshi children aged 2–5 years drinking groundwater with a high level of iron | 12.5 mg | 30 mg | 60 days | — |
| Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam 2016 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required | 8.57 mg | 10 mg | 56 weeks | 508 |
| The effect of iron-vitamin C co-supplementation on biomarkers of oxidative stress in iron-deficient female youth 2013 · 50 mg/day elemental iron + 500 mg/day ascorbic acid · Iron-deficient, non-anemic girls | 50 mg | 500 mg | 12 weeks | — |
| Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial 2020 · intervention group · Adults aged 18–80 undergoing elective hip or knee replacement | 30 mg | 70 mg | 30 days | 37 |
| Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron 1997 · Pure non-heme iron with vitamin C · Pregnant women in the second half of pregnancy | 27 mg | — | — | 30 |
| Iron deficiency in young basketball players: Is a 100 μg/L ferritin cut-off appropriate for iron supplementation?: Results of a randomized placebo-controlled study 2023 · iron supplementation group · male basketball players under 19 years with ferritin below 100 μg/L | 160 mg | 30 mg | 90 days | 26 |
| Oral use of iron with vitamin C in hemodialyzed patients 2003 · Sorbifer Durules · Adults with end-stage renal disease receiving hemodialysis and recombinant human erythropoietin | 100 mg | 60 mg | 4 weeks | 24 |
| Iron absorption from a breakfast cereal: effects of EDTA compounds and ascorbic acid 2001 · Hydrogen reduced iron plus ascorbic acid · Non-anaemic female volunteers | 3.75 mg | 15 mg | 2 days | 20 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 2) · Infants; age and health status not reported | 2.5 mg | 25 mg | 4 days | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 50 mg ascorbic acid (study 2) · Infants; age and health status not reported | 2.5 mg | 50 mg | 4 days | 9 |
| A single high dose of ascorbic acid and iron is not correlated with oxidative stress in healthy volunteers 2008 · 2 g of AA plus 150 mg of iron carbonyl · Healthy, nonsmoking men aged 20–31 years | 150 mg | 2 g | 1 day | 9 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferric pyrophosphate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 2.5 mg | 25 mg | 4 days | 8 |
| Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate 2000 · [57Fe]ferrous fumarate with 25 mg ascorbic acid (study 1) · Infants; age and health status not reported | 2.5 mg | 25 mg | 4 days | 8 |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Chromagen · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Feosol · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Niferex · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 100 mg | 26 weeks | — |
| Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin 1995 · Tabron · Dialysis patients receiving recombinant human erythropoietin | 200 mg | 100 mg | 26 weeks | — |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 27 mg | 85 mg | 165 days | 749 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 27 mg | 85 mg | — | 176 |
| The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial 2021 · Lp group · Healthy, non-anemic pregnant women aged 18–42 years, with singleton pregnancies and iron-replete status at enrollment | 8.4 mg | 24 mg | — | 120 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 140 mg | 184 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 140 mg | 184 days | 75 |
| Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants 2007 · mineral/micronutrient (MMN) · Cambodian infants aged 6 months at enrolment | 12.5 mg | — | 1 year | 68 |
| A randomized trial of once daily versus twice daily dosing of oral iron in CKD 2023 · OD group · Adults aged 18–70 with stage 3–4 chronic kidney disease and transferrin saturation ≤30% and serum ferritin ≤500; both sexes | 100 mg | — | 12 weeks | 40 |
| A randomized trial of once daily versus twice daily dosing of oral iron in CKD 2023 · BD group · Adults aged 18–70 with stage 3–4 chronic kidney disease and transferrin saturation ≤30% and serum ferritin ≤500; both sexes | 200 mg | — | 12 weeks | 40 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Non-liposomal multivitamin (NL) · Healthy males and females aged 18–65 years | 9 mg | 110 mg | 1 day | 34 |
| Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations 2023 · Liposomal multivitamin (L) · Healthy males and females aged 18–65 years | 9 mg | 110 mg | 1 day | 34 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 20 mg | 100 mg | 12 weeks | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group II · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 200 mg | 100 mg | 30 days | 32 |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement 2013 · Group III · Female regular blood donors; age range and health conditions beyond regular blood donation not specified | 200 mg | 500 mg | 30 days | 32 |
| Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status 2022 · Group 2 (Ferachel Forte; ferric sodium EDTA combination) · Adults over 18 with functional iron-deficiency anemia and moderate CKD stage 3a–3b | 30 mg | — | 26 weeks | 22 |
| Do iron and vitamin C co-supplementation influence platelet function or LDL oxidizability in healthy volunteers? 1999 · Group A · Healthy adult volunteers; sex and age range not stated | 14 mg | 60 mg | 12 weeks | 20 |
| Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants 2014 · MNP + Fe · Breastfed infants enrolled just before 6 months of age and followed to approximately 9 months; healthy, with hemoglobin ≥10 g/dL and no malaria parasites at enrollment | 12.5 mg | 30 mg | 90 days | 15 |
| Effect of Iron Supplementation on the Modulation of Iron Metabolism, Muscle Damage Biomarkers and Cortisol in Professional Cyclists 2019 · Iron-treated group (ITG) · Professional male cyclists, ages 25.7 ± 6.4 years; medically screened and free of disease | 80 mg | 1 g | 4 weeks | 9 |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 30 mg | 50 mg | 13 weeks | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferrous fumarate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | — | 270 days | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferric pyrophosphate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | — | 270 days | — |
| Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children 2009 · ferrous sulfate group · Children aged 7–24 months with hemoglobin >105 g/L | 9.3 mg | — | 270 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · daily supplementation group · female Indonesian high-school adolescents | 60 mg | 60 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (60 mg Fe) · female Indonesian high-school adolescents | 8.57 mg | 8.57 mg | 90 days | — |
| Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents 1997 · weekly supplementation group (120 mg Fe) · female Indonesian high-school adolescents | 17.1 mg | 8.57 mg | 90 days | — |
| Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh 2016 · MMS · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years | 30 mg | 70 mg | — | 439 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · LNS · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 20 mg | 100 mg | — | 418 |
| Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi 2015 · MMN · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation | 20 mg | 100 mg | — | 415 |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 12.5 mg | 30 mg | 60 days | 254 |
| Multiple micronutrient supplementation improves micronutrient status in primary school children in Hai Phong City, Vietnam: a randomised controlled trial 2021 · intervention · Children aged 6–9 years, apparently healthy, in rural Hai Phong City, Vietnam; included undernourished, normal-weight, and overweight/obese children | 10 mg | 30 mg | 22 weeks | 175 |
| Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study 2025 · Group A (test) · Pregnant women aged 20–35 years, at 13–16 weeks’ gestation, with iron-deficiency anemia (hemoglobin 9–10.5 g/dL and serum ferritin <15 mcg/L) | 27 mg | 50 mg | 4 weeks | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 8 mg | 20 mg | 90 days | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.86 mg | 2.86 mg | 90 days | 54 |
| Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy 2017 · Reference (standard-of-care) arm · Pregnant women aged 18–45 years, recruited at 14–22 weeks’ gestation in rural Gambia; healthy at enrolment, with varying anaemia and iron status | 60 mg | 70 mg | 12 weeks | — |